SCHEMBL10355484

SCHEMBL10355484

CCCCc1ccc(O)c(CCCC)c1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.62
HTT P42858 2/20 0.47
HPGD P15428 2/20 0.47
NPC1 O15118 1/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALOX5 P09917 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ELANE P08246 4/20 0.45
CTSG P08311 4/20 0.45
PRKCI P41743 1/20 0.44
PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28322027 0.96 TYR (0.69) TYRHTTHPGDNPC1MAPK1
SCHEMBL20357473 0.94 TYR (0.71) TYRHTTALOX5MEN1KMT2A
Hydrochloric Acid SCHEMBL27870692 0.92 TYR (0.69) TYRHTTALOX5MEN1KMT2A
SCHEMBL10345469 0.92 TYR (0.74) TYRHTTALOX5MEN1KMT2A
SCHEMBL8936705 0.92 TYR (0.74) TYRHTTALOX5MEN1KMT2A
SCHEMBL1957156 0.92 TYR (0.74) TYRHTTALOX5MEN1KMT2A
SCHEMBL14682176 0.90 TYR (0.56) TYRHTTHPGDNPC1MAPK1
SCHEMBL1005744 0.88 TYR (0.56) TYRHTTHPGDNPC1MAPK1
SCHEMBL167918 0.86 TYR (0.55) TYRHTTHPGDNPC1MAPK1
SCHEMBL7544746 0.85 HPGD (0.52) TYRHTTHPGDNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190124918-A1 BIOFILM FORMATION INHIBITOR AND BIOFILM FORMATION INHIBITING COMPOSITION KAO CORPORATION (JP) 2019-05-02 US disclosed
CN-109219349-A Composition is used in biofilm formating inhibitor and biofilm formation inhibition 花王株式会社 2019-01-15 CN disclosed
CN-102604475-A Radiation-curable ink for inkjet, recorded matter, and inkjet recording method SEIKO EPSON CORP 2012-07-25 CN disclosed
CN-102558958-A Radiation-curable ink composition for inkjet, recorded matter, and inkjet recording method SEIKO EPSON CORP 2012-07-11 CN disclosed
CN-102471149-A Radiation curable coatings for optical fibers DSM IP ASSETS BV 2012-05-23 CN disclosed
CN-1302021-C Non-aqueous absorbent and use thereof SANYO CHEMICAL IND LTD (JP) 2007-02-28 CN disclosed
CN-1239567-C Crystalline epoxy, its producing method and solidifiable composition containing the same NIPPON EPOXY CO LTD (JP) 2006-02-01 CN disclosed
CN-1220729-C Epoxy resin composition and method of producing the same NIPPON EPOXY RESIN CO LTD (JP) 2005-09-28 CN disclosed
CN-1653146-A Radiation curable coating composition DSM IP ASSETS BV (NL) 2005-08-10 CN disclosed
CN-1203104-C Epoxy resin composition for semiconductor encapsulation RESOLUTION RES NEDERLAND BV (NL) 2005-05-25 CN disclosed
CN-1610703-A Non-aqueous absorbent and use thereof SANYO CHEMICAL IND LTD (JP) 2005-04-27 CN disclosed
CN-1518578-A Curing agent for epoxy resins and epoxy resin composition О 2004-08-04 CN disclosed
CN-1487963-A Epoxy resin composition for semiconductor encapsulation О 2004-04-07 CN disclosed
CN-1361191-A Crystalline epoxy, its producing method and solidifiable composition containing the same NIPPON EPOXY CO LTD (JP) 2002-07-31 CN disclosed
CN-1350032-A Epoxy resin composition and method of producing the same NIPPON EPOXY RESIN CO LTD (JP) 2002-05-22 CN disclosed
EP-0232618-B1 BIOCIDE AND METHOD FOR PROTECTING ORGANIC MATERIALS INDSPEC CHEMICAL CORPORATION (US) 1990-08-08 EP disclosed
EP-0232618-A1 Biocide and method for protecting organic materials INDSPEC CHEMICAL CORPORATION (US) 1987-08-19 EP disclosed
US-4645780-A FUNGICIDES, BACTERICIDES KOPPERS COMPANY, INC. (US) 1987-02-24 US disclosed
US-4129413-A Oxidation hair dyes based upon tetraaminopyrimidine developers and mono- and dialkyl -m- dihydroxy benzene couplers HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1978-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190124918-A1 BIOFILM FORMATION INHIBITOR AND BIOFILM FORMATION INHIBITING COMPOSITION BLVRB, O60361, TFPI TYR 468/4885HTT 2611/4885HPGD 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.